Free Trial

Jamieson Wellness (TSE:JWEL) Shares Down 0.8% - Here's What Happened

Jamieson Wellness logo with Consumer Defensive background

Shares of Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) were down 0.8% during trading on Thursday . The stock traded as low as C$34.77 and last traded at C$35.00. Approximately 14,091 shares were traded during trading, a decline of 66% from the average daily volume of 41,285 shares. The stock had previously closed at C$35.27.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on JWEL. BMO Capital Markets upped their price target on shares of Jamieson Wellness from C$42.00 to C$46.00 in a report on Thursday, December 19th. TD Securities boosted their price target on Jamieson Wellness from C$40.00 to C$42.00 and gave the company a "buy" rating in a report on Friday, November 8th. National Bankshares increased their price objective on Jamieson Wellness from C$36.50 to C$42.00 in a report on Monday, November 25th. Finally, Royal Bank of Canada upped their price target on Jamieson Wellness from C$37.00 to C$38.00 in a research report on Friday, November 8th.

Get Our Latest Stock Analysis on Jamieson Wellness

Jamieson Wellness Stock Performance

The stock has a market capitalization of C$1.45 billion, a P/E ratio of 40.70 and a beta of 0.63. The stock has a 50 day simple moving average of C$36.11 and a two-hundred day simple moving average of C$33.62. The company has a quick ratio of 1.08, a current ratio of 3.21 and a debt-to-equity ratio of 92.76.

Jamieson Wellness Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 13th. Stockholders of record on Friday, December 13th were paid a dividend of $0.21 per share. The ex-dividend date was Friday, November 29th. This is a positive change from Jamieson Wellness's previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a dividend yield of 2.40%. Jamieson Wellness's payout ratio is currently 97.67%.

Insiders Place Their Bets

In other Jamieson Wellness news, Senior Officer Regan Stewart sold 1,300 shares of the firm's stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of C$37.84, for a total value of C$49,192.00. Insiders sold 11,237 shares of company stock worth $407,455 over the last three months. Insiders own 0.26% of the company's stock.

Jamieson Wellness Company Profile

(Get Free Report)

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Jamieson Wellness Right Now?

Before you consider Jamieson Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.

While Jamieson Wellness currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines